Boston Advisors’s Sanofi SNY Stock Holding History

Boston Advisors’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-11,215	Closed	-$482K	–	666
2017 Q4	$482K	Buy	11,215 +3,495	+45%	+$161K	0.01%	494
2017 Q3	$384K	Sell	7,720 -5,590	-42%	-$270K	0.01%	538
2017 Q2	$638K	Buy	+13,310	New	+$636K	0.01%	440
2013 Q4	–	Sell	-5,915	Closed	-$299K	–	603
2013 Q3	$299K	Sell	5,915 -676	-10%	-$34.4K	0.02%	419
2013 Q2	$340K	Buy	+6,591	New	+$351K	0.02%	374

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Advisors's SNY Position: Q1 2018 in Review

Boston Advisors sold out of Sanofi (SNY) in Q1 2018, closing a stake of 11,215 shares — an estimated $482K sold.

Boston Advisors first reported a position in SNY in Q2 2013 and held it in 5 quarters. The position peaked at $638K in Q2 2017. 487 funds tracked by Wall St. Rank hold SNY as of Q1 2018.

Boston Advisors reported no remaining Sanofi position as of Q1 2018 after selling out during the quarter.
Boston Advisors sold 11,215 Sanofi shares in Q1 2018, an estimated $482K.
Boston Advisors first reported a position in Sanofi in Q2 2013 and held it in 5 quarters.
Boston Advisors's Sanofi position peaked at $638K in Q2 2017.
487 funds tracked by Wall St. Rank held Sanofi as of Q1 2018.

Based on Boston Advisors's 13F filing for Q1 2018, filed 25 Apr 2018.